HIND
NASDAQ
$2.16
ReShape Lifesciences Inc (HIND)
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company is headquartered in Princeton, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $11.50 (+432.41%)
Market Cap
$16M
Free Cash Flow Yield
-19.24%
Price Chart
Valuation
Market Cap$16M
P/S104.32
P/B2.26
Profitability
Total Revenue (TTM)-$762K
Gross Profit (TTM)$81K
EBITDA-$11M
Operating Margin-3577%
EPS-$4.01
Financial Health
Free Cash Flow Yield-19.24%
Growth & Risk
FCF 5Y CAGR-17.15%
Sharpe Ratio-0.86